Literature DB >> 10840419

Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma.

S Baltaci1, D Orhan, S Soyupek, Y Bedük, O Tulunay, O Gögüs.   

Abstract

PURPOSE: We assessed the influence of clinical and pathological factors on multifocality of renal cell carcinoma.
MATERIALS AND METHODS: Between June 1995 and September 1999 radical nephrectomy was performed in 71 men and 32 women with a mean age of 56.5 years. The 103 removed kidneys with renal cell carcinoma were sectioned at 3 mm. intervals and inspected microscopically for satellite carcinomas. We evaluated pathological stage, grade, cell type, histological pattern, vascular involvement, tumor size and the incidence of multifocality. To determine cell type we used several classification systems.
RESULTS: The primary tumor was 2 to 20 cm. (mean plus or minus standard deviation 7.10 +/- 3.48). Overall satellite carcinomas were present in 22 of the 103 cases (21.4%). When the predominant lesion was 5 cm. or smaller, the incidence of multifocality was 19%. The incidence of multifocality was statistically higher in patients with stage pT3 than in those with stage pT1 or pT2 disease (p = 0.022). Multiple logistic regression analysis demonstrated that only primary tumor pathological stage was a significant predictor of renal cell carcinoma multifocality in stages T3 versus T1 and T3 versus T2 cancer (odds ratio 3.45, 95% confidence interval 1.15 to 10.39 and 5.75, 1.31 to 25.29, respectively). Other parameters, such as tumor size, grade, vascular invasion, cell type and histological pattern, did not correlate with multifocality.
CONCLUSIONS: Our results imply that primary tumor stage is a significant factor for multifocal disease. Therefore, more precise preoperative staging of the primary lesion is required if nephron sparing surgery is indicated.

Entities:  

Mesh:

Year:  2000        PMID: 10840419

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Long-term management of bilateral, multifocal, recurrent renal carcinoma.

Authors:  Gennady Bratslavsky; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

2.  De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression.

Authors:  Rachelle Asciak; Jesmar Buttigieg; Louis Buhagiar
Journal:  CEN Case Rep       Date:  2015-11-02

3.  Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.

Authors:  M Kuczyk; G Wegener; A S Merseburger; A Anastasiadis; S Machtens; A Zumbrägel; J T Hartmann; C Bokemeyer; Udo Jonas; A Stenzl
Journal:  World J Urol       Date:  2005-02-24       Impact factor: 4.226

Review 4.  Oncological outcomes of partial nephrectomy for tumours larger than 4 cm: A systematic review.

Authors:  Tarek H El-Ghazaly; Ross J Mason; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

5.  Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.

Authors:  G Li; D Zhu; H Gao; H Chen; Y Li; Y Niu
Journal:  Clin Transl Oncol       Date:  2018-11-15       Impact factor: 3.405

Review 6.  Nephron-sparing surgery for multifocal and hereditary renal tumors.

Authors:  Adam R Metwalli; William M Linehan
Journal:  Curr Opin Urol       Date:  2014-09       Impact factor: 2.309

7.  Initial experience with robot assisted partial nephrectomy for multiple renal masses.

Authors:  Ronald Boris; Miguel Proano; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

Review 8.  Preoperative imaging in renal cell cancer.

Authors:  Axel Heidenreich; Vincent Ravery
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

9.  Decreasing the indications for radical nephrectomy: a study of multifocal renal cell carcinoma.

Authors:  Maximiliano Sorbellini; Gennady Bratslavsky
Journal:  Front Oncol       Date:  2012-08-06       Impact factor: 6.244

10.  Multifocal renal cell carcinoma: clinicopathologic features and outcomes for tumors </=4 cm.

Authors:  Paul L Crispen; Christine M Lohse; Michael L Blute
Journal:  Adv Urol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.